GLUCAGON-BASED THERAPY FOR PEOPLE WITH DIABETES AND OBESITY: WHAT IS THE SWEET SPOT?

Descargar Publicación
Dual and Triple Incretin-Based Co-agonists: Novel Therapeutics for Obesity and Diabetes Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial